BioLife Solutions Inc (BLFS)

Days of sales outstanding (DSO)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Receivables turnover 11.22 6.86 6.96 7.37 7.65 6.27 6.01 5.35 4.75 4.76 4.72 5.69 5.12 4.77 3.51 4.95 6.01 6.77 8.43 4.09
DSO days 32.53 53.18 52.44 49.52 47.69 58.20 60.73 68.18 76.92 76.64 77.34 64.11 71.31 76.46 103.96 73.79 60.77 53.93 43.30 89.16

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 11.22
= 32.53

Days Sales Outstanding (DSO) is a key metric used to evaluate how efficiently a company is managing its accounts receivable. In the case of BioLife Solutions Inc, the trend in DSO over the periods from March 2020 to December 2024 shows some fluctuations.

- The DSO was 89.16 days in March 2020, indicating a relatively long period of time taken by the company to collect its outstanding receivables.
- By June 2020, the DSO decreased significantly to 43.30 days, suggesting an improvement in the company's ability to collect payments from customers.
- However, there was an increase in DSO in the subsequent quarters, reaching a peak of 103.96 days in June 2021, which may raise concerns about the company's credit policies or the quality of its receivables.
- BioLife Solutions Inc managed to decrease its DSO in the following quarters, with fluctuations ranging between 47.69 days in December 2023 to 77.34 days in June 2022.
- By December 2024, the DSO decreased substantially to 32.53 days, indicating an improvement in the company's efficiency in collecting payments from customers.

Overall, it is essential for BioLife Solutions Inc to monitor its DSO closely to ensure that it maintains an optimal balance between maximizing sales and managing its working capital effectively. A lower DSO generally indicates better liquidity and efficient management of accounts receivable.